AbbVie has joined many of its big pharma peers by signing a Most-Favoured Nation (MFN) drug pricing deal with the Trump administration to avoid tariffs – sweetened with a promise to invest $100 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results